CXCL16 and leukemia: To exclude the possibility that the increase in CXCL16 accumulation in the spleens of B-ALL mice was due to the high leukemia burden, we measured CXCL16 expression on a per-cell basis in primary B-ALL cells after rmIL-17A treatment by FACS.